drugset / Trial / NCT02856152
A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
This open-label, randomized, 4-way crossover study in healthy participants will determine the relative bioavailability of the tablet formulation relative to the capsule formulation and the effect of a high-fat and low-fat meal on the relative bioavailability of the tablet formulation.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-11
- Completion
- 2016-11
Outcome
Outcome not reported
Stopped: “The molecule (GDC-276) is no longer in development.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RG7893 | Unknown | 270 mg | Oral |
Indications
No indication recorded.